HK1122985A1 - Agent for improving insulin resistance - Google Patents

Agent for improving insulin resistance

Info

Publication number
HK1122985A1
HK1122985A1 HK09100023.2A HK09100023A HK1122985A1 HK 1122985 A1 HK1122985 A1 HK 1122985A1 HK 09100023 A HK09100023 A HK 09100023A HK 1122985 A1 HK1122985 A1 HK 1122985A1
Authority
HK
Hong Kong
Prior art keywords
insulin resistance
agent
pathosis
adipocytokines
improving insulin
Prior art date
Application number
HK09100023.2A
Other languages
English (en)
Inventor
Miyuki Tanaka
Eriko Misawa
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1122985A1 publication Critical patent/HK1122985A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09100023.2A 2005-09-30 2009-01-02 Agent for improving insulin resistance HK1122985A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005287884 2005-09-30
PCT/JP2006/318809 WO2007043302A1 (ja) 2005-09-30 2006-09-22 インスリン抵抗性改善剤

Publications (1)

Publication Number Publication Date
HK1122985A1 true HK1122985A1 (en) 2009-06-05

Family

ID=37942553

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09100023.2A HK1122985A1 (en) 2005-09-30 2009-01-02 Agent for improving insulin resistance

Country Status (11)

Country Link
US (1) US8236769B2 (xx)
EP (1) EP1930013B1 (xx)
JP (1) JP4169777B2 (xx)
KR (1) KR100941016B1 (xx)
CN (1) CN101272795B (xx)
AU (1) AU2006300637C1 (xx)
CA (1) CA2613041C (xx)
ES (1) ES2575515T3 (xx)
HK (1) HK1122985A1 (xx)
RU (1) RU2379037C2 (xx)
WO (1) WO2007043302A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006293136B2 (en) * 2005-09-22 2010-01-14 Morinaga Milk Industry Co., Ltd. Agent for inhibiting visceral fat accumulation
KR101331772B1 (ko) * 2008-11-19 2013-11-22 모리나가 뉴교 가부시키가이샤 항산화제
ES2719098T3 (es) * 2008-11-19 2019-07-08 Morinaga Milk Industry Co Ltd Composiciones que comprenden un lofenol
LT2900230T (lt) 2012-09-27 2019-01-10 The Children`S Medical Center Corporation Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai
ES2813424T3 (es) * 2014-03-26 2021-03-23 Childrens Medical Ct Corp Derivados de celastrol para el tratamiento de la obesidad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214741A (ja) 1984-04-05 1985-10-28 Toyo Yakushiyoku Kogyo Kk 血糖降下剤
JP3862295B2 (ja) 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
JPH0812573A (ja) 1994-06-24 1996-01-16 Mitsubishi Chem Corp 遊離脂肪酸低下剤
JP3685833B2 (ja) 1995-02-06 2005-08-24 日本メナード化粧品株式会社 免疫抑制改善剤
JP3966922B2 (ja) * 1996-07-18 2007-08-29 一丸ファルコス株式会社 線維芽細胞増殖促進剤
JPH10298100A (ja) 1997-05-06 1998-11-10 Mitsubishi Chem Corp インスリン抵抗性に起因する疾患の予防及び／又は治療剤
JP3873097B2 (ja) 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
JP4499209B2 (ja) * 1999-05-10 2010-07-07 日本メナード化粧品株式会社 肥満の予防改善剤
JP3858055B2 (ja) 2000-02-29 2006-12-13 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
JP2001247473A (ja) 2000-03-06 2001-09-11 Kao Corp インスリン抵抗性改善剤
JP2002193797A (ja) 2000-12-22 2002-07-10 Mitsukan Group Honsha:Kk インスリン抵抗性改善用組成物
WO2003063894A1 (fr) 2002-01-31 2003-08-07 Japan Science And Technology Agency Agents ameliorant la resistance a l'insuline
JP2003286185A (ja) * 2002-03-29 2003-10-07 Daily Foods Kk アロエベラ圧搾液及び該圧搾液を有効成分とする血糖値降下剤
US6884783B2 (en) 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
JP4846990B2 (ja) 2003-08-06 2011-12-28 株式会社テラ・ブレインズ アディポネクチン分泌促進剤
US7534770B2 (en) 2004-03-31 2009-05-19 Morinaga Milk Industry Co., Ltd. Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent
WO2005094838A1 (ja) * 2004-03-31 2005-10-13 Morinaga Milk Industry Co., Ltd. 高血糖改善のための医薬及び飲食品
JP3924310B2 (ja) 2004-09-29 2007-06-06 森永乳業株式会社 高血糖改善のための医薬及び飲食品

Also Published As

Publication number Publication date
KR100941016B1 (ko) 2010-02-05
RU2007143530A (ru) 2009-06-27
CA2613041C (en) 2012-03-06
JP4169777B2 (ja) 2008-10-22
EP1930013A4 (en) 2010-01-13
JPWO2007043302A1 (ja) 2009-04-16
CN101272795A (zh) 2008-09-24
AU2006300637B2 (en) 2009-12-10
EP1930013B1 (en) 2016-03-23
KR20080016827A (ko) 2008-02-22
US20090312275A1 (en) 2009-12-17
AU2006300637C1 (en) 2010-07-01
WO2007043302A1 (ja) 2007-04-19
RU2379037C2 (ru) 2010-01-20
EP1930013A1 (en) 2008-06-11
AU2006300637A1 (en) 2007-04-19
ES2575515T3 (es) 2016-06-29
US8236769B2 (en) 2012-08-07
CN101272795B (zh) 2013-04-03
CA2613041A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
BRPI0914348A2 (pt) Método para melhorar a saúde de uma planta cultivada, usos de pelo menos um composto, fruto e semente
TW200637488A (en) Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
WO2007133721A3 (en) Food compositions and methods of treating periodontal disease
WO2006069241A3 (en) Methods for promoting oral health in animals
WO2009060012A3 (en) Plant health compositions comprising a beneficial microorganism and a pesticide
WO2011055018A3 (en) Feed composition comprising bark extract and the use of bark extract
WO2008132021A3 (de) Fungizide mischungen
NO20055620L (no) Bruksklar sammensetning imfattende fiskeolje og juice og fremstilling av denne, samt en forseglet beholder.
HK1122985A1 (en) Agent for improving insulin resistance
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2011163319A3 (en) Activation of amp-protein activated kinase by oxaloacetate compounds
WO2007075255A3 (en) Mastic gum composition for use as a dietary supplement in humans and animals
WO2007142984A3 (en) Nutritional formulations and associated methods
WO2007062248A3 (en) Insecticidal compositions and uses thereof
WO2011041079A3 (en) Adjuvant for agricultural chemicals
WO2009129208A8 (en) Compositions and methods of inducing endoplasmic reticulum stress reponse
WO2019017603A3 (ko) 마름 추출물 및 커큐민을 유효성분으로 함유하는 숙취 개선용 조성물
WO2009027382A3 (de) Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
WO2016190566A3 (ko) 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품
WO2009050905A1 (ja) 呈味改善用組成物、これを添加した飲食物、及びこれらの製造方法
WO2011065791A3 (ko) 황기 추출물을 포함하는 대사 촉진 조성물
WO2009041699A1 (ja) 防風通聖散配合製剤
WO2013085338A3 (ko) 수련뿌리 추출물, 이의 분획물 또는 이로부터 분리된 폴리페놀계 화합물을 유효성분으로 함유하는 대사성 질환 예방 및 치료용 약학적 조성물
MY155276A (en) Botanical extracts from oil palm vegetation liquor cosmeceutical applications

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200920